These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 6159988)

  • 21. Cellular transfer of experimental allergic encephalomyelitis in Lewis rats: effects of different sensitization regimens on in vitro reactivity of donor spleen cells to concanavalin A.
    Ovadia H; Paterson PY
    Cell Immunol; 1981 Nov; 65(1):66-74. PubMed ID: 6172201
    [No Abstract]   [Full Text] [Related]  

  • 22. Durability of immune protection against experimental autoimmune encephalomyelitis.
    Bernard CC; Mackay IR; Whittingham S; Brous P
    Cell Immunol; 1976 Mar; 22(2):297-310. PubMed ID: 58731
    [No Abstract]   [Full Text] [Related]  

  • 23. Rhesus diploid rabies vaccine (adsorbed): neurological safety in guinea pigs and Lewis rats.
    Levenbook IS; Elisberg BL; Driscoll BF
    Vaccine; 1986 Dec; 4(4):225-7. PubMed ID: 2432737
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Delayed hypersensitivity to myelin basic protein in the passive transfer of experimental allergic encephalomyelitis.
    Falk GA; Kies MW; Alvord EC
    J Immunol; 1968 Oct; 101(4):638-44. PubMed ID: 4971475
    [No Abstract]   [Full Text] [Related]  

  • 25. Mycobacterial suppression of delayed hypersensitivity in experimental allergic encephalomyelitis.
    Lisak RP; Kies MW
    Proc Soc Exp Biol Med; 1968 May; 128(1):214-8. PubMed ID: 4968539
    [No Abstract]   [Full Text] [Related]  

  • 26. Experimental allergic encephalomyelitis: changes in growth and proliferation within the draining lymph node following injection of basic encephalitogenic protein in Freund's complete adjuvant.
    Matous-Malbohan I; Holub M; Krásenská J; Marĕs V; Lodin Z
    Cell Immunol; 1974 Jun; 12(3):350-62. PubMed ID: 4142422
    [No Abstract]   [Full Text] [Related]  

  • 27. Adoptive transfer of experimental allergic encephalomyelitis: incubation of rat spleen cells with specific antigen.
    Richert JR; Driscoll BF; Kies MW; Alvord EC
    J Immunol; 1979 Feb; 122(2):494-6. PubMed ID: 84024
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Alpha-fetoprotein suppresses experimental allergic encephalomyelitis.
    Abramsky O; Brenner T; Mizrachi R; Soffer D
    J Neuroimmunol; 1982 Jan; 2(1):1-7. PubMed ID: 6185533
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Induction and suppression of experimental allergic encephalomyelitis in the non-human primate.
    Rauch HC; Einstein ER
    J Neurol Sci; 1974 Sep; 23(1):99-116. PubMed ID: 4136815
    [No Abstract]   [Full Text] [Related]  

  • 30. Spontaneous remission and acquired resistance to autoimmune encephalomyelitis (EAE) are associated with suppression of T cell reactivity: suppressed EAE effector T cells recovered as T cell lines.
    Ben-Nun A; Cohen IR
    J Immunol; 1982 Mar; 128(3):1450-7. PubMed ID: 6173439
    [No Abstract]   [Full Text] [Related]  

  • 31. Cell-mediated immunity to myelin basic protein in Lewis rats made unresponsive to experimental allergic encephalomyelitis.
    McGraw TP; Swanborg RH
    Eur J Immunol; 1978 Dec; 8(12):905-9. PubMed ID: 365547
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Chronic relapsing experimental allergic encephalomyelitis. Correlation of circulating lymphocyte fluctuations with disease activity in suppressed and unsuppressed animals.
    Traugott U; Stone SH; Raine CS
    J Neurol Sci; 1979 Mar; 41(1):17-29. PubMed ID: 86602
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cellular and genetic basis of the relative resistance to the induction of experimental allergic encephalomyelitis (EAE) in albino oxford (AO) rats.
    Mostarica-Stojkovic M; Petrovic M; Lukic ML
    Adv Exp Med Biol; 1982; 149():699-702. PubMed ID: 6216773
    [No Abstract]   [Full Text] [Related]  

  • 34. Autoimmune diseases and thalidomide. II. Adjuvant disease, experimental allergic encephalomyelitis and experimental allergic neuritis of the rat.
    Goihman-Yahr M; Requena MA; Vallecalle-Suegart E; Convit J
    Int J Lepr Other Mycobact Dis; 1974; 42(3):266-75. PubMed ID: 4218599
    [No Abstract]   [Full Text] [Related]  

  • 35. Regulation of experimental allergic encephalomyelitis. Part 4. Further characterization of postrecovery suppressor cells.
    Killen JA; Swanborg RH
    J Neuroimmunol; 1982 Oct; 3(2):159-66. PubMed ID: 6181092
    [TBL] [Abstract][Full Text] [Related]  

  • 36. CHRONIC DISSEMINATED ALLERGIC ENCEPHALOMYELITIS IN GUINEA PIGS.
    STONE SH; LERNER EM
    Ann N Y Acad Sci; 1965 Mar; 122():227-41. PubMed ID: 14313480
    [No Abstract]   [Full Text] [Related]  

  • 37. Regulation of experimental allergic encephalomyelitis. III. Demonstration of effector cells in tolerant rats.
    Holda JH; Swanborg RH
    Eur J Immunol; 1981 Apr; 11(4):338-40. PubMed ID: 6166483
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Minimum structural requirements for encephalitogen and for adjuvant in the induction of experimental allergic encephalomyelitis.
    Nagai Y; Akiyama K; Suzuki K; Kotani S; Watanabe Y; Shimono T; Shiba T; Kusumoto S; Ikuta F; Takeda S
    Cell Immunol; 1978 Jan; 35(1):158-67. PubMed ID: 74289
    [No Abstract]   [Full Text] [Related]  

  • 39. Abrogation of induced resistance to experimental allergic encephalomyelitis in guinea pigs by host-versus-graft reaction.
    Kozovska M; Staykova M; Goranov I
    J Neuroimmunol; 1990; 29(1-3):157-63. PubMed ID: 1698813
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Suppression of experimental allergic encephalomyelitis with thoracic duct lymphocytes.
    Frost H; Swanborg RH
    Int Arch Allergy Appl Immunol; 1980; 63(2):153-8. PubMed ID: 6158482
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.